The possible role of red blood cell microvesicles in atherosclerosis

European Journal of Internal Medicine

Volumn 20, Issue 2, 2009, Pages 101-105

  Blum, Arnon ^a  

^a NHLBI   (United States)

Author keywords

Atherosclerosis; Endothelial function; Red blood cells' microvesicles; Sickle cell disease

Indexed keywords

LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; REACTIVE OXYGEN METABOLITE;

ATHEROSCLEROSIS; ERYTHROCYTE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MICROVASCULATURE; REVIEW; SICKLE CELL; SMOOTH MUSCLE FIBER;

ANEMIA, SICKLE CELL; ANIMALS; ATHEROSCLEROSIS; ERYTHROCYTES; HUMANS; MICROVESSELS; OXIDATIVE STRESS; VASCULITIS;

EID: 62649097275     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2008.06.001     Document Type: Review

References (62)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362 (1993) 801-809
2. Munro J.M., and Cotran R.S. The pathogenesis of atherosclerosis: atherogenesis and inflammation. Lab Invest 58 (1988) 249-261
3. Berliner J.A., Navab M., Fogelman A.M., et al. Atherosclerosis: basic mechanisms. Oxidation, inflammation and genetics. Circulation 91 (1995) 2488-2496
4. Libby P. Molecular bases of the acute coronary syndromes. Circulation 91 (1995) 2844-2850
5. Sato T., Takebayashi S., and Kohchi K. Increased subendothelial infiltration of the coronary arteries with monocytes/macrophages in patients with unstable angina: histological data on 14 autopsied patients. Atherosclerosis 68 (1987) 191-197
6. Van der Wal A.C., Becker A.E., Van der Loos C.M., and Das P.K. Site of intimal rupture or erosion of thrombosed atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 89 (1994) 36-44
7. Cyb0ulsky M.I., and Gimbrone M.A. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 52 (1991) 788-791
8. Pigott R., Dillon L.P., Hemingway I.H., and Gearing A.J.H. Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. Bio Biophys Res Commun 187 (1992) 584-589
9. Marui N., Offermann M.K., Swerlick R., et al. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J Clin Invest 92 (1993) 1866-1874
10. Nakai K., Itoh C., Kawazone K., et al. Concentration of soluble vascular cell adhesion molecule-1 (VCAM-1) is correlated with expression of VCAM-1 mRNA in the human atherosclerotic aorta. Coron Art Dis 6 (1995) 497-502
11. Davies M.J., Gordon J.L., Gearing A.J.H., et al. The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis. J Pathol 171 (1993) 223-229
12. Van der Wal A.C., Das P.K., Tigges A.J., and Becker A.E. Adhesion molecules on the endothelium and mononuclear cells in human atherosclerotic lesions. Am J Pathol 141 (1992) 1427-1433
13. O'Brien K.D., McDonald T.O., Chait A., Allen M.D., and Alpers C.E. Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. Circulation 93 (1996) 672-682
14. Peng H.B., Libby P., and Liao J.K. Induction and stabilization of Ik{cyrillic}Bα by nitric oxide mediates inhibition of NFk{cyrillic}B. J Biol Chem 270 (1995) 14214-24219
15. De caterina R., Libby P., Peng H.B., et al. Nitric oxide decreases cytokine-induced activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 96 (1995) 60-68
16. Peng H.B., Rajarashisth T.B., Libby P., and Liao J.K. Nitric oxide inhibits macrophage-colony stimulating factor gene transcription in vascular endothelial cells. J Biol Chem 40 (1991) 794-799
17. Zeiher A.H., Fisslhalter B., Schray Utz B., and Busse R. Nitric oxide modulates the expression of monocyte chemotactic protein 1 in cultured human endothelial cells. Circ Res 76 (1995) 980-986
18. Tsao P.S., Wang B., Buitrago R., Shyy J.Y., and Cooke J.P. Nitric oxide regulates monocyte chemotactic protein-1. Circulation 96 3 (1997) 934-940
19. Quyyumi A.A., Dakak N., Andrew N.P., et al. Nitric oxide activity in the human coronary circulation. JCI 95 4 (1995) 1747-1755
20. Quyyumi A.A., Dakak N., Mulcahy D., et al. Nitric oxide activity in the atherosclerotic human coronary circulation. J Am Coll Cardiol 29 (1997) 308-317
21. Casino P.R., Kilcoyne C.M., Quyyumi A.A., Hoeg J.M., and Panza J.A. The role of n nitric oxide in endothelium-dependent vasodilation of hypercholesterolemic patients. Circulation 88 (1993) 2541-2547
22. Mazzone A., De Servi S., Giovanni R., et al. Increased expression of neutrophil and monocyte adhesion molecules in unstable coronary artery disease. Circulation 88 (1993) 358-363
23. Haught W.H., Mansour M., Rothlein R., et al. Alterations in circulating intercellular adhesion molecule-1 and L-selectin: further evidence for chronic inflammation in ischemic heart disease. Am Heart J 132 (1995) 1-8
24. Blann A.D., Amiral J., and McCollum C.N. Circulating endothelial cell/leukocyte adhesion molecules in ischemic heart disease. British Journal of Haematology 95 (1996) 263-265
25. Liuzzo G., Biasucci L.M., Gallimore J.R., et al. The prognostic value of C-reactive protein and serum amyloid type A protein in severe unstable angina. N Engl J Med 331 (1994) 417-424
26. Biasucci L.M., Vitelli A., Liuzzo G., et al. Elevated levels of interleukin-6 in unstable angina. Circulation 94 5 (1996) 874-877
27. Ridker P.M., Glynn R.J., and Hennekens C.H. C-reactive protein adds to the predictive value of total and HDL-cholesterol in determining risk of first myocardial infarction. Circulation 97 (1998) 2007-2011
28. Blum A., Sclarovsky S., and Shohat B. T lymphocyte activation in stable angina pectoris and after percutaneous transluminal coronary angioplasty. Circulation 91 (1995) 20-22
29. Kuller L., Tracy R., Shaten J., Meilahn E., and for the MRFIT Research Group. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Am J Epidemiol 144 (1996) 537-547
30. Morrow D.A., Rifai N., Antman E.M., et al. C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. J Am Coll Cardiol 31 (1998) 1460-1465
31. Hwang S.J., Ballantyne C.M., Sharrett R., et al. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases. The Atherosclerosis Risk in Communities (ARIC) study. Circulation 96 (1997) 4219-4225
32. Belch J.J.F., Shaw J.W., Kirk G., et al. The white blood cell adhesion molecule E-selectin predicts restenosis in patients with intermittent claudication undergoing percutaneous transluminal angioplasty. Circulation 95 (1997) 2027-2031
33. Inoue T., Sakai Y., Hashi K., Yaguchi I., Fujito T., and Morooka S. Lower expression of neutrophil adhesion molecule indicates less vessel wall injury and might explain lower restenosis rate after cutting balloon angioplasty. Circulation 97 (1998) 2511-2518
34. Inoue T., Saki Y., Morooka S., Hayashi T., Takayanagi K., and Takabatake Y. Expression of polymorphonuclear leukocyte adhesion molecules and its clinical significance in patients treated with percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 28 (1996) 1127-1133
35. Ridker P.M., Hennekens C.H., Roitman-Hohnson B., Stampfer M.J., and Allen J. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet 351 (1998) 88-92
36. Miesel S.R., Shapir H., Radnay J., et al. Increased expression of neutrophil and monocyte adhesion molecules LFA-1 and Mac-1 and their ligand ICAM-1 and VLA-4 throughout the acute phase of myocardial infarction. J Am Coll Cardiol 31 (1998) 120-125
37. Blum A., Yeganeh S., Peleg A., et al. Endothelial function in patients with sickle cell anemia during and after sickle cell crises. J thromb Thrombolysis 19 2 (2005) 83-86
38. Emburi S.H., Hebbe R.P., Steinberg M.H., and Mohandas N. Pathogenesis of vasoocclusion. In: Embury S.H., Hebbel R.P., Steinberg M.H., and Mohandas N. (Eds). Sickle cell disease: basic principles and clinical practice (1994), Raven Press, New York 311-325
39. Hebbel R.P. Adhesive interactions of sickle erythrocytes with endothelium. J Clin Invest 99 (1997) 2561-2564
40. Kaul D.K., Fabry M.E., and Nagel R.L. Erythrocytic and vascular factors influencing the microcirculatory behavior of blood in sickle cell anemia. Ann N Y Acad Sci 565 (1989) 316-326
41. Hebbel R.P., and Vercellotti G.M. The endothelial biology of sickle cell disease. J Lab Clin Med 129 (1997) 288-293
42. Hebbel R.P. Blockade of adhesion of sickle cells to endothelium by monoclonal antibodies. NEJM 342 (2000) 1910-1912
43. Belhassen L., Pelle G., Sediame S., et al. Endothelial dysfunction in patients with sickle cell disease is related to selective impairment of shear stress-mediated vasodilation. Blood 97 6 (2001) 1584-1589
44. Berckmans R.J., Nieuwland R., Boing A.N., Romijn F., Hack C.E., and Sturk A. Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost 85 (2001) 639-646
45. Wagner M.C., Eckman J.R., and Wick T.M. Sickle cell adhesion depends on hemodynamics and endothelial activation. Journal of Laboratory and Clinical Medicine 144 5 (2004) 260-267
46. Kato G.J., Martyr S., Blackwelder W.C., et al. Levels of soluble endothelium-derived adhesion molecules in patients with sickle cell disease are associated with pulmonary hypertension, organ dysfunction, and mortality. Br J Haematol 130 6 (2005) 943-953
47. Horne M.K., Cullinane A.M., Merryman P.K., and Hoddeson E.K. The effect of red blood cells on thrombin generation. Br J Haematol 133 (2006) 403-408
48. Lin H., Xu X., Lu H., et al. Pathological mechanisms and dose dependency of erythrocyte-induced vulnerability of atherosclerotic plaques. Journal of Molecular and Cellular Cardiology 43 (2007) 272-280
49. Boulanger C.M., Amabile N., and Tedgui A. Circulating microparticles. A potential prognostic marker for atherosclerotic vascular disease. Hypertension 48 2 (2006) 180-186
50. Palek J., and Lux S.E. Red cell membrane skeletal defects in hereditary and acquired hemolytic anemias. Semin Hematol 20 (1983) 189
51. Zarkowsky H.S., Mohandas N., Speaker C.B., and Shohet S.B. A congenital haemolytic anaemia with thermal sensitivity of the erythrocyte membrane. Br J Haematol 29 (1975) 537
52. Liu S.-C., Palek J., Prchal J., and Castleberry R.P. Altered spectrin dimer-dimer association and instability of erythrocyte membrane skeletons in hereditary pyropoikilocytosis. J Clin Invest 68 (1981) 597
53. Smith D.K., and Palek J. Sulfhydryl reagents induce altered spectrin self-association, skeletal instability, and increased thermal sensitivity of red cells. Blood 62 (1983) 1190
54. Zarkowksy H.S. Membrane-active agents and heat-induced erythrocyte fragmentation. Br J Haematol 50 (1982) 361
55. Rank B.H., Carlsson J., and Hebbel R.P. Abnormal redox status of membrane protein thiols in sickle erythrocytes. J Clin Invest 75 (1985) 1531
56. Padilla F., Bromberg P.A., and Jensen W.N. The sickle-unsickle cycle: a cause of cell fragmentation leading to permanently deformed cells. Blood 41 (1973) 653
57. Allan D., Limbrick A.R., Thomas P., and Westerman M.P. Release of spectrin-free spicules on reoxygenation of sickled erythrocytes. Nature 295 (1982) 612
58. Allan D., Limbrick A.R., Thomas P., and Westerman M.P. Microvesicles from sickle erythrocytes and their relation to irreversible sickling. Br J Haematol 47 (1981) 383
59. Maridonneau I., Braquet P., and Garay R.P. Na and K transport damage induced by oxygen free radicals in human red cell membranes. J Biol Chem 258 (1983) 3107
60. Hebbel R.P., Shalev O., Foker W., and Rank B.H. Inhibition of erythrocyte calcium-ATPase by activated oxygen through thiol- and lipid-dependent mechanisms. Biochim Biophys Ata 862 (1986) 8
61. Biro E., Sturk-Maquelin K.N., Vogel G.M.T., et al. Human cell-derived microparticles promote thrombus formation in vivo in a tissue factor dependent manner. J Thromb Haemostasis 1 (2003) 2561-2568
62. Tan K.T., and Lip G.Y.H. The potential role of platelet microparticles in atherosclerosis. Thromb haemost 94 (2005) 488-492